- Alpha-galactosidase A deficiency
- Fabry disease, a genetic disorder. The enzyme alpha-galactosidase A is essential to the metabolism of molecules known as glycosphingolipids. Without the enzyme, glycosphingolipids accumulate in the kidneys, heart, nerves and throughout the body, causing Fabry disease. Males with Fabry disease are more severely affected than females since the gene for Fabry disease is on the X chromosome. Males have only one X while females have a second X and therefore some enzyme activity. Boys with Fabry disease usually have discomfort of the hands and feet with abnormal sensation (paresthesia) or burning pain by adolescence. Red raised lesions known as angiokeratomas occur on the skin and within the mouth. The ability to sweat is decreased. The cornea and lens of the eye become clouded. There may be painful abdominal crises. Renal impairment may require dialysis or kidney transplant. The kidney failure may cause hypertension. Heart function can be impaired. Females with partial enzyme activity may not show any symptoms or only late in life. Impaired heart function may be their primary problem. Diagnosis is made by determining the level of alpha-galactosidase A in blood plasma or by genetic testing to detect the abnormal gene. Treatment is by enzyme replacement. Twice weekly infusions of recombinant galactosidase A have been found to be safe and effective in clearing deposits from the kidney blood vessels, myocardium (heart muscle), and skin. In August 2001 the European Union granted orphan drug status to two forms of recombinant galactosidase A — Replagal (agalsidase alfa) and Fabrazyme (agalsidase beta) — for long-term enzyme replacement in Fabry disease. In Europe, orphan drug status means no third party can compete with them for 10 years. Neither Replagal nor Fabrazyme had received approval in the United States.
Medical dictionary. 2011.
Look at other dictionaries:
Alpha-galactosidase — is a glycoside hydrolase enzyme that hydrolyses the terminal alpha galactosyl moieties from glycolipids and glycoproteins. It is encoded by the gene|GLA gene. PBB Summary section title = summary text = Chemistry This enzyme is a homodimeric… … Wikipedia
Deficiency, alpha-galactosidase A — Fabry disease, a genetic disorder. The enzyme alpha galactosidase A is essential to the metabolism of molecules known as glycosphingolipids. Without the enzyme, glycosphingolipids accumulate in the kidneys, heart, nerves and throughout the body,… … Medical dictionary
Fabry disease — ICD10 = E75.2 (ILDS E75.25) Classification and external resources Alpha galactosidase the protein that is deficient in Fabry disease … Wikipedia
Список наследственных заболеваний — Список генетических заболеваний Основные статьи: наследственные заболевания, Наследственные болезни обмена веществ, Ферментопатия. В большинстве случаев приведен также код, указывающий на тип мутации и связанные с ней хромосомы. См. также система … Википедия
Morbus Fabry — Klassifikation nach ICD 10 E75.2 Sonstige Sphingolipidosen (inkl. Fabry (Anderson )Krankheit) … Deutsch Wikipedia
NAGA (gene) — N acetylgalactosaminidase, alpha Rendering based on PDB 3H53 … Wikipedia
Hexosaminidase — β N acetylhexosaminidase Hexosaminidase A (Hex A) Identifiers EC number 220.127.116.11 … Wikipedia
Prominent metabolic diseases — ▪ Table Prominent metabolic diseases disorder cause signs and symptoms treatment cystinosis lysosomal cystine transporter defect rickets, dehydration, stunted growth, kidney disease, corneal deposits supportive therapy, cysteamine, kidney… … Universalium
Fabry disease — A genetic disease due to deficiency of an enzyme called alpha galactosidase A. This enzyme is essential to the metabolism of molecules known as glycosphingolipids. Without the enzyme, glycosphingolipids accumulate in the kidneys, heart, nerves… … Medical dictionary
Morbus Kanzaki — Klassifikation nach ICD 10 E74.2 Störungen des Galaktosestoffwechsels … Deutsch Wikipedia